Migraine Treatment Options
For acute episodic migraine treatment, start with NSAIDs or acetaminophen, and if inadequate relief occurs, add a triptan (combination therapy of triptan plus NSAID or acetaminophen provides superior relief compared to monotherapy). 1
First-Line Treatment Options
For Mild to Moderate Migraines:
NSAIDs (first choice):
- Ibuprofen 400-800mg
- Naproxen 500mg
- Aspirin 900mg
- Diclofenac potassium 1
Acetaminophen:
For Moderate to Severe Migraines:
Triptans (when NSAIDs provide inadequate relief):
Combination therapy (most effective approach):
- Triptan + NSAID (e.g., sumatriptan + naproxen)
- Triptan + acetaminophen (when NSAIDs contraindicated) 1
Second-Line and Alternative Options
For Patients with Inadequate Response to First-Line Treatments:
CGRP antagonists (gepants):
Ergot alkaloids:
- Dihydroergotamine (DHE) 1
Ditan:
For Migraine with Significant Nausea/Vomiting:
- Non-oral routes of administration:
Treatment Algorithm
Assess migraine severity:
- Mild to moderate: Start with NSAID or acetaminophen
- Moderate to severe: Consider triptan or combination therapy immediately
If initial treatment fails:
- Add a triptan to NSAID/acetaminophen
- Try different triptan if first one ineffective
- Consider non-oral route if nausea/vomiting present
For refractory cases:
- Try CGRP antagonists or DHE
- Consider lasmiditan as last resort
- Evaluate for preventive therapy if attacks are frequent
Important Clinical Considerations
- Timing matters: Treat early in the attack for better efficacy 1, 4
- Avoid overuse: Medication overuse headache can occur with frequent use (≥15 days/month for NSAIDs; ≥10 days/month for triptans) 1
- Never use opioids or butalbital for migraine treatment due to dependency risk, rebound headaches, and loss of efficacy 1, 2
- Consider preventive therapy if migraine occurs frequently or treatment doesn't provide adequate response 1
Evidence Quality and Efficacy
- Sumatriptan 100mg shows superior efficacy with NNT of 4.7 for pain-free at 2 hours compared to placebo 4
- Combination therapy of triptan + NSAID/acetaminophen shows greater net benefit than monotherapy 1
- Early treatment during mild pain phase gives significantly better outcomes than treating established attacks 4
- Subcutaneous sumatriptan has faster onset (1 hour) with higher response rates (70-84%) compared to oral formulation (50-67% at 2 hours) 5
Common Pitfalls to Avoid
- Not addressing nausea as a component of migraine
- Overusing acute medications leading to medication overuse headache
- Using opioids or butalbital-containing medications
- Not considering non-oral routes when needed for patients with significant nausea/vomiting
- Failing to start treatment early in the attack
By following this evidence-based approach to migraine treatment, focusing on NSAIDs/acetaminophen for mild attacks and adding triptans for moderate-severe attacks, patients can achieve better control of their migraine symptoms and improved quality of life.